Task Force 10: Clinical Considerations for the Care of Masters Athletes with Underlying Cardiovascular Disease
Masters athletes are individuals ≥35 yr of age who place a high premium on exercise training and competition. This document details important cardiovascular conditions, risk factors, and data-driven discussion, which serve as the rationale for Section X from the 2025 AHA/ACC Scientific Statement: Clinical Considerations for Competitive Sports Participation for Athletes Cardiovascular Abnormalities. Disease-specific risk stratification and shared decision-making are the cornerstones for Masters athletes when considering competitive sports participation. Coronary artery disease, atrial fibrillation, incidental myocardial fibrosis, aortic enlargement and aneurysms, and valvular heart disease are included in this Task Force document.
Authors
- Eugene H. Chung (ORCID: https://orcid.org/0000-0002-7514-627X)
- Elizabeth H. Dineen (ORCID: https://orcid.org/0000-0002-4704-4495)
- Jonathan H. Kim (ORCID: https://orcid.org/0000-0001-5885-0284)
- Aaron Leigh Baggish (ORCID: https://orcid.org/0000-0003-2042-1489)
- Mats B rjesson
- Paul D. Thompson (ORCID: https://orcid.org/0000-0002-0365-2149)
- Thijs M H Eijsvogels (ORCID: https://orcid.org/0000-0003-0747-4471)
- BENJAMIN D. LEVINE
Institutions
- Hartford Hospital (US)
- Harvard University (US)
- Emory University (US)
- Sahlgrenska University Hospital (SE)
- Radboud University Medical Center (NL)
- Massachusetts General Hospital (US)
- Institute for Exercise and Environmental Medicine (US)
- Mayo Clinic in Florida (US)
- The University of Texas Southwestern Medical Center (US)
- University of Gothenburg (SE)
- University of Lausanne (CH)
Publication Details
- Journal
- Medicine & Science in Sports & Exercise
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1249/mss.0000000000004098
- Primary Topic
- Cardiovascular Effects of Exercise
- Type
- article
- Field-Weighted Citation Impact
- 0.00